Dec 31, 2017
The Erdheim-Chester Disease Global Alliance adds four new ECD Care Centers in Canada and Europe.
Dec 31, 2017
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation.
Dec 31, 2017
Assuta Medical Center joins an elite group of hospitals skilled in treating Erdheim-Chester disease patients.
Dec 31, 2017
The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Australia.
Dec 31, 2017
First FDA-Approved drug for this rare disease
